A. Lerga et al., DOWN-REGULATION OF C-MYC AND MAX GENES IS ASSOCIATED TO INHIBITION OFPROTEIN PHOSPHATASE 2A IN K562 HUMAN LEUKEMIA-CELLS, Biochemical and biophysical research communications, 215(3), 1995, pp. 889-895
Treatment of the human myeloid leukemia K562 cells with the protein ph
osphatase inhibitors okadaic acid or calyculin A resulted in down-regu
lation of both c-myc and max genes at the mRNA and protein levels. The
extent of the down-regulation was similar for both genes and was depe
ndent on the dose and on the treatment time. Interestingly, c-myc and
max down-regulation was concomitant with apoptosis induced by okadaic
acid and calyculin A in K562 cells. The expression of c-myc and max re
turned to control levels after the removal of okadaic acid from the me
dia, although apoptosis was irreversible. These effects were observed
at okadaic acid concentrations (15 nM) that inhibited the activity of
protein phosphatase type 2A but not of phosphatase type 1. We conclude
that the inhibition of protein phosphatase 2A is associated to decrea
sed levels of c-Myc/Max heterodimers in K562 cells. (C) 1995 Academic
Press, Inc.